Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study

Cornea
Yohan BenayounPierre-Yves Robert

Abstract

To evaluate the effect of subconjunctival bevacizumab injections in patients with corneal neovascularization resulting from different ocular surface disorders. Prospective case series. Twelve eyes of 11 patients with corneal neovascularization caused by different ocular surface disorders, such as healed corneal ulcers, long-standing chronic inflammatory diseases, and corneal ischemia secondary to burn, were included. All eyes received a single subconjunctival injection of 2.5 mg (0.1 mL) of bevacizumab. Morphological changes in neovascularization were evaluated during 3 months using slit-lamp biomicroscopy, corneal digital photography, and computer-assisted semiautomatic analysis of corneal neovascularization area. Recession of corneal vessels was observed in all eyes at 1 week postinjection. The surface of the neovascular tree continued to decrease noticeably for 1 month and then increased again for the remainder of the follow-up period. The corneal neovascularization area amounted to 11.25 ± 4.49% of the corneal surface preinjection, compared with 8.44 ± 3.37% postinjection (P = 0.02), reflecting a mean decrease in corneal neovascularization of 25%. No local or systemic adverse events possibly related to subconjunctival bevac...Continue Reading

References

Jun 11, 1999·Journal of Cancer Research and Clinical Oncology·J M SchlaeppiJ Wood
Oct 12, 2000·Eye·I M Russell-EggittJ W Walker
Aug 17, 2001·Current Opinion in Ophthalmology·J H ChangD T Azar
Jun 5, 2004·The Oncologist·Nishan H Fernando, Herbert I Hurwitz
Jul 28, 2004·Investigative Ophthalmology & Visual Science·Claus CursiefenJ Wayne Streilein
Jul 4, 2006·American Journal of Ophthalmology·Ziad F BashshurBaha' N Noureddin
Jul 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Claus CursiefenReza Dana
Jan 25, 2007·Acta Ophthalmologica Scandinavica·Marcus KerntAnselm Kampik
Mar 8, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ivan Goldberg, Robert Ritch
Apr 27, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Mesut Erdurmus, Yuksel Totan
May 26, 2007·Investigative Ophthalmology & Visual Science·Felix BockClaus Cursiefen
Jun 15, 2007·Archives of Ophthalmology·John J DeStafeno, Terry Kim
Aug 28, 2007·Cornea·Efdal YoeruekPeter Szurman
Oct 16, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Felix BockClaus Cursiefen
Oct 30, 2007·Journal of Cataract and Refractive Surgery·Ahmed Awadein
Nov 1, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rishikesh P DalalWillem D F Venter
Nov 14, 2007·Clinical & Experimental Ophthalmology·Hamid HosseiniFarajollah Noori
Jan 22, 2008·American Journal of Ophthalmology·Miltiadis PapathanassiouIoannis A Vergados
Jan 25, 2008·Cornea·Irit BaharAllan Slomovic
Apr 29, 2008·Ophthalmology·Sang Woo KimTae-im Kim
May 20, 2008·Investigative Ophthalmology & Visual Science·Charles Q YuMark I Rosenblatt
Sep 25, 2008·Cornea·Jenna Buley
Sep 25, 2008·Cornea·Priyanka P DoctorC Stephen Foster
Jan 20, 2009·Investigative Ophthalmology & Visual Science·Felix BockClaus Cursiefen
Apr 24, 2009·Cornea·Kakarla V ChalamRajesh K Sharma
May 6, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yanyan KoenigClaus Cursiefen
Jun 13, 2009·Acta Ophthalmologica·Ahmed A Zaki, Samar F Farid
Aug 15, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Petja Ivanova Vassileva, Tatyana Georgieva Hergeldzhieva
Nov 7, 2009·Investigative Ophthalmology & Visual Science·Mohammad H DastjerdiReza Dana
Jan 27, 2010·Progress in Retinal and Eye Research·David EllenbergJin-Hong Chang
Dec 3, 2010·Investigative Ophthalmology & Visual Science·Marta Ugarte, Tom H Williamson

❮ Previous
Next ❯

Citations

Feb 12, 2013·Journal of Neural Transmission·Anna ÉnzsölyJános Németh
Aug 24, 2013·Journal français d'ophtalmologie·Y BenayounP-Y Robert
Nov 1, 2013·Asia-Pacific Journal of Ophthalmology·Annabel C Y ChewDonald T H Tan
Mar 20, 2020·Current Drug Targets·Giuseppe GiannaccareMassimo Busin
Jan 15, 2021·Case Reports in Ophthalmology·Anna Krystyna Britton, Basil Bamford Crayford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.